Onfolio Holdings Inc

This management proposal seeks shareholder approval under Nasdaq Listing Rule 5635(d) to permit the Company to issue, under an equity purchase facility entered into on April 10, 2026, more than 19.99% of its outstanding common stock at a discount to the Nasdaq-defined Minimum Price. Management is pursuing the Equity Facility to obtain up to $100 million of flexible capital available through advances, with proceeds designated for cryptocurrency reserve asset purchases (25%) and working capital/general corporate purposes (75%). Nasdaq approval is required because issuances exceeding 19.99% at a price below the Minimum Price are subject to stockholder approval to remain compliant with Nasdaq rules. The Board frames the Facility as necessary to address the Company's capital needs and to help remediate a Nasdaq deficiency notice relating to minimum stockholders’ equity, potentially avoiding suspension or delisting. The proposal acknowledges dilution risk and potential adverse market impact from the ongoing availability of shares for sale, but the Board argues that the capital access and regulatory compliance benefits outweigh those risks. The Facility includes contractual limits such as a beneficial ownership cap for the investor (9.99%) and no minimum draw requirement, and the Company paid a one-time commitment fee in the form of 50,000 shares. If shareholders do not approve this proposal, the Company would be constrained from issuing more than 19.99% to the Investor, which could limit its ability to raise capital under the Facility and may force repeated adjournments of the meeting to continue solicitation. For an analyst, key considerations include the trade-off between near-term dilution and preserving Nasdaq listing status, the terms of the Equity Facility (pricing discounts, beneficial ownership limits, commitment structure), and the Company’s stated reliance on the proceeds to address regulatory/compliance shortfalls and working capital needs.

This management-sponsored charter amendment requests stockholder approval to double the Company’s authorized common stock from 300 million to 600 million shares, primarily to ensure compliance with the Equity Facility’s share reservation requirements and to provide the Board flexibility for future corporate needs. The Board states the increase is necessary to reserve and register shares issuable under the Equity Facility and to have shares available for acquisitions, capital raises, stock plans, and other corporate purposes without needing immediate further stockholder action. The amendment, if adopted, would not by itself issue shares but would enable future issuances that could materially dilute existing holders and affect earnings-per-share and voting power. Management emphasizes the operational and timing efficiencies of having authorized shares available, citing potential delays and costs of repeatedly seeking shareholder approval. An important contextual factor is the Company’s Nasdaq deficiency notice on minimum stockholders’ equity; the Board links the charter amendment to enabling capital-raising options to regain listing compliance. From a governance lens, investors should weigh the dilution risk and the potential anti-takeover effects management acknowledges against the company’s near-term capital needs and strategic flexibility. Analysts should also examine the Company’s explicit statement that, aside from existing obligations, there are currently no firm plans to issue the additional authorized shares, and monitor any subsequent issuances for magnitude, pricing, and potential related-party or strategic transactions.

The adjournment proposal is a procedural measure permitting the Company to adjourn and reconvene the Annual Meeting to continue solicitation efforts if one or more substantive proposals fail to receive the required votes. Management intends this primarily as a mechanism to obtain shareholder approval for the Equity Facility and Authorized Share Increase should those proposals fall short at the initial meeting, thus avoiding the need to schedule an entirely new meeting. Approving adjournment authority can be viewed as a practical contingency to preserve strategic options, but it may also signal to the market that management expects resistance to certain proposals and plans to continue pressuring for approval. The adjournment mechanic can impose additional costs and extend the period of uncertainty for shareholders, potentially impacting share liquidity and market perception. It also increases the window for further solicitations and outreach, which could change the final vote outcome if persuasive communications or additional commitments are made. From a governance perspective, investors should consider whether adjournment authority could be used opportunistically to alter the circumstances of a vote, though the Company states revocable proxies allow previously voting shareholders to change their votes before any adjourned meeting. Analysts should monitor subsequent solicitation materials and any changes in proposal terms or disclosures made between the initial meeting and any reconvened sessions.